Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked ...

Diabetes silently damages eyes by weakening retinal blood vessels, leading to vision loss through conditions like retinopathy ...

Retina Blood Vessel Damage: Diabetes affects not only the heart, kidneys, liver, and nerves, but also the eyes. Many people ...

The percentage of adults with diabetes who self-reported vision problems decreased from 26 percent in 1997 to 18.6 percent in 2010, according to a Center for Disease Control report. The actual number ...

Headlines warning about “Ozempic blindness” may be frightening to the millions of people taking a GLP-1 drug to treat Type 2 diabetes or for weight loss. It's not an official diagnosis, but an ...

Dec 12 (Reuters) - Vision loss likely related to diabetes in the United States increased by 20 percent over less than a decade, according to a U.S. study - a matter of concern as diabetes rates ...

Blockbuster GLP-1 medications like Ozempic and Mounjaro might sharpen your figure, but they could also cloud your vision in the process. A review published in JAMA Ophthalmology uncovered at least ...

The diabetes drugs Ozempic and Wegovy have been linked to an increased risk of sudden vision loss and blindness due to a rare eye condition known as NAION (non-arteritic anterior ischemic optic ...

A medicine used by millions of people around the world to manage type 2 diabetes is now being closely studied for a possible ...

Ozempic blindness isn’t a real diagnosis. It’s a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, ...

Diabetes is a disease where a person’s body can’t regulate sugar properly. Over time it can lead to serious health complications, including heart attack, stroke, vision loss, kidney problems and nerve ...